Tag Archives: Little Elm’s Retractable Technologies lands big contracts to supply COVID-19 vaccination syringes

Little Elm-based Retractable Technologies will supply syringes to the U.S. government under two contracts totaling $137.4 million for vaccination efforts once a COVID-19 treatment is developed. The contracts will help the company ramp up U.S. production of its retractable needles, it said in regulatory filings. Retractable won a $53.6 million contract on July 1 to expand its manufacturing capacity under …

Read More »